如果你想投资成功的大型生物技术，最大的两个是安进（Amgen）和新基（Celgene）。过去10年来，这两只股票都增长了两倍多。 Are there any negatives for Celgene? Yep. The biotech is highly dependent on blood cancer drug Revlimid, which generates around 63% of Celgene's total revenu...